HUP9901336A2 - Heteroaril-szubsztituált akriloil-guanidin-származékok és azokat tartalmazó gyógyászati kompozíciók - Google Patents
Heteroaril-szubsztituált akriloil-guanidin-származékok és azokat tartalmazó gyógyászati kompozíciókInfo
- Publication number
- HUP9901336A2 HUP9901336A2 HU9901336A HUP9901336A HUP9901336A2 HU P9901336 A2 HUP9901336 A2 HU P9901336A2 HU 9901336 A HU9901336 A HU 9901336A HU P9901336 A HUP9901336 A HU P9901336A HU P9901336 A2 HUP9901336 A2 HU P9901336A2
- Authority
- HU
- Hungary
- Prior art keywords
- heteroaryl
- substituted
- sub
- optionally substituted
- medicinal composition
- Prior art date
Links
- UWICDWBEVIDNNJ-UHFFFAOYSA-N n-(diaminomethylidene)prop-2-enamide Chemical class NC(=N)NC(=O)C=C UWICDWBEVIDNNJ-UHFFFAOYSA-N 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 206010002383 Angina Pectoris Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 208000007107 Stomach Ulcer Diseases 0.000 abstract 1
- 206010003119 arrhythmia Diseases 0.000 abstract 1
- 230000006793 arrhythmia Effects 0.000 abstract 1
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
- C07D207/327—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
A találmány (I) általánős képletű heterőaril-szűbsztitűált akrilőil-gűanidin-származékőkra és azők sóira vőnatkőzik, ahől a képletben Ajelentése 5 tagú vagy 6 tagú heterőarilcsőpőrt, amely adőtt esetbenszűbsztitűált lehet, és adőtt esetben kőndenzálva lehet egy vagy kétbenzőlgyűrűvel; a B gyűrű jelentése adőtt esetben szűbsztitűáltarilcsőpőrt, és R1 jelentése hidrőgénatőm, halőgénatőm vagy rövidszénláncú alkilcsőpőrt, amely adőtt esetben szűbsztitűálva lehet egyvagy több halőgénatőmmal. Ezek a vegyületek az Na+/H+ kicserélődésinhibitőraként hatnak, és ezért hasznősak a gyógyászatban, különösenaz Na+H+ kicserélődés által őkőzőtt különböző rendellenességek, ígymagas vérnyőmás, aritmia, angina pectőris, arteriőszkleórzis,diabéteszes rendellenességek és hasőnlók megelőzésében, kezelésében ésdiagnősztizálásában. ŕ
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP24171695 | 1995-09-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP9901336A2 true HUP9901336A2 (hu) | 1999-08-30 |
HUP9901336A3 HUP9901336A3 (en) | 2000-02-28 |
Family
ID=17078479
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9901336A HUP9901336A3 (en) | 1995-09-20 | 1996-09-19 | Heteroaryl-substituted acryloylguanidine derivatives and medicinal composition thereof |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0861831A4 (hu) |
KR (1) | KR19990063589A (hu) |
CN (1) | CN1196721A (hu) |
AU (1) | AU702092B2 (hu) |
BR (1) | BR9610530A (hu) |
CA (1) | CA2232497A1 (hu) |
CZ (1) | CZ84098A3 (hu) |
HU (1) | HUP9901336A3 (hu) |
NO (1) | NO981241L (hu) |
PL (1) | PL326033A1 (hu) |
SK (1) | SK35198A3 (hu) |
WO (1) | WO1997011055A1 (hu) |
ZA (1) | ZA967800B (hu) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5942516A (en) * | 1995-08-02 | 1999-08-24 | Elliott; John Duncan | Endothelin receptor antagonists |
JP3652708B2 (ja) * | 1997-03-06 | 2005-05-25 | トーアエイヨー株式会社 | シクロアルカ[b]ピリジン−3−カルボニルグアニジン誘導体、その製造法およびそれを含有する医薬品 |
WO2001014363A1 (en) * | 1999-08-23 | 2001-03-01 | Smithkline Beecham Corporation | Fatty acid synthase inhibitors |
WO2002051441A1 (fr) * | 2000-12-26 | 2002-07-04 | Sankyo Company, Limited | Compositions medicinales contenant un diuretique et un agent renforçant la resistance a l'insuline |
NZ552031A (en) | 2004-06-16 | 2009-06-26 | Wyeth Corp | Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase |
JP2008503460A (ja) | 2004-06-16 | 2008-02-07 | ワイス | β−セクレターゼのインヒビターとしてのジフェニルイミダゾピリミジンおよびイミダゾールアミン |
JP2008526966A (ja) | 2005-01-14 | 2008-07-24 | ワイス | β−セクレターゼの阻害のためのアミノ−イミダゾロン |
AU2006211159A1 (en) | 2005-02-01 | 2006-08-10 | Wyeth | Amino-pyridines as inhibitors of beta-secretase |
BRPI0606902A2 (pt) | 2005-02-14 | 2009-07-28 | Wyeth Corp | composto; método para o tratamento de uma doença ou distúrbio associado a atividade excessiva de bace em um paciente que dele necessite; método para modular a atividade de bace; composição farmacêutica |
WO2006088694A1 (en) | 2005-02-14 | 2006-08-24 | Wyeth | SUBSTITUTED THIENYL AND FURYL ACYLGUANIDINES AS β-SECRETASE MODULATORS |
WO2007005404A1 (en) | 2005-06-30 | 2007-01-11 | Wyeth | AMINO-5-(6-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR ß-SECRETASE MODULATION |
TW200738683A (en) | 2005-06-30 | 2007-10-16 | Wyeth Corp | Amino-5-(5-membered)heteroarylimidazolone compounds and the use thereof for β-secretase modulation |
BRPI0616757A2 (pt) | 2005-09-26 | 2011-06-28 | Wyeth Corp | composto da fórmula i; processo para o tratamento de uma doença ou de um distúrbio associado com a atividade excessiva de bace; processo para a modulação da atividade de bace; processo para o tratamento da doença de alzheimer; e composição farmacêutica |
WO2007100536A1 (en) | 2006-02-24 | 2007-09-07 | Wyeth | DIHYDROSPIRO[DIBENZO[A,D][7]ANNULENE-5,4'-IMIDAZOL] COMPOUNDS FOR THE INHIBITION OF β-SECRETASE |
US7700606B2 (en) | 2006-08-17 | 2010-04-20 | Wyeth Llc | Imidazole amines as inhibitors of β-secretase |
AR065814A1 (es) | 2007-03-23 | 2009-07-01 | Wyeth Corp | Derivados de 5-fenilimidazolona,inhibidores de beta-secretasa,composiciones farmaceuticas que los contienen y usos para prevenir y/o tratar trastornos asociados a niveles beta-amiloides elevados. |
WO2018065288A1 (de) | 2016-10-07 | 2018-04-12 | Bayer Cropscience Aktiengesellschaft | 2-[2-phenyl-1-(sulfonylmethyl)vinyl]-imidazo[4,5-b]pyridin-derivate und verwandte verbindungen als schädlingsbekämpfungsmittel im pflanzenschutz |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3929582A1 (de) | 1989-09-06 | 1991-03-07 | Hoechst Ag | Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament |
DE59302959D1 (de) * | 1992-02-15 | 1996-07-25 | Hoechst Ag | 3,5-Substituierte Benzoylguanidine, mit antiarrythmischer Wirkung und inhibierender Wirkung auf die Proliferationen von Zellen |
JP3162572B2 (ja) * | 1993-04-28 | 2001-05-08 | 住友製薬株式会社 | インドロイルグアニジン誘導体 |
US5401758A (en) * | 1993-10-07 | 1995-03-28 | Bristol-Myers Squibb Company | Pyridinyl cyanoguanidine compounds |
DE4430861A1 (de) * | 1994-08-31 | 1996-03-07 | Merck Patent Gmbh | Heterocyclyl-benzoylguanidine |
JPH0959245A (ja) * | 1995-08-25 | 1997-03-04 | Yamanouchi Pharmaceut Co Ltd | N−(2−プロペノイル)グアニジン誘導体 |
-
1996
- 1996-09-16 ZA ZA967800A patent/ZA967800B/xx unknown
- 1996-09-19 PL PL96326033A patent/PL326033A1/xx unknown
- 1996-09-19 WO PCT/JP1996/002696 patent/WO1997011055A1/ja not_active Application Discontinuation
- 1996-09-19 AU AU70007/96A patent/AU702092B2/en not_active Ceased
- 1996-09-19 BR BR9610530A patent/BR9610530A/pt not_active Application Discontinuation
- 1996-09-19 HU HU9901336A patent/HUP9901336A3/hu unknown
- 1996-09-19 CZ CZ98840A patent/CZ84098A3/cs unknown
- 1996-09-19 CN CN96196999A patent/CN1196721A/zh active Pending
- 1996-09-19 SK SK351-98A patent/SK35198A3/sk unknown
- 1996-09-19 KR KR1019980702028A patent/KR19990063589A/ko not_active Application Discontinuation
- 1996-09-19 CA CA002232497A patent/CA2232497A1/en not_active Abandoned
- 1996-09-19 EP EP96931252A patent/EP0861831A4/en not_active Withdrawn
-
1998
- 1998-03-19 NO NO981241A patent/NO981241L/no unknown
Also Published As
Publication number | Publication date |
---|---|
AU702092B2 (en) | 1999-02-11 |
NO981241D0 (no) | 1998-03-19 |
SK35198A3 (en) | 1999-06-11 |
EP0861831A4 (en) | 1998-11-11 |
BR9610530A (pt) | 1999-07-06 |
AU7000796A (en) | 1997-04-09 |
CZ84098A3 (cs) | 1998-09-16 |
WO1997011055A1 (fr) | 1997-03-27 |
EP0861831A1 (en) | 1998-09-02 |
PL326033A1 (en) | 1998-08-17 |
NO981241L (no) | 1998-05-20 |
ZA967800B (en) | 1997-04-03 |
CA2232497A1 (en) | 1997-03-27 |
KR19990063589A (ko) | 1999-07-26 |
MX9802238A (es) | 1998-08-30 |
CN1196721A (zh) | 1998-10-21 |
HUP9901336A3 (en) | 2000-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9901336A2 (hu) | Heteroaril-szubsztituált akriloil-guanidin-származékok és azokat tartalmazó gyógyászati kompozíciók | |
HUP0001446A2 (hu) | HIV reverz transzkriptáz inhibitor hatású 4,4-diszubsztituált-3,4-dihidro-2(1H)-kinazolinon-származékok, alkalmazásuk és a vegyületeket tartalmazó gyógyszerkészítmények | |
RU95108329A (ru) | Замещенные производные тиазолидиндиона, способ их получения, фармкомпозиция | |
HUP0203312A2 (hu) | Farmakológiailag hatékony szulfonamidszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
HUP9801882A2 (hu) | Szulfinsav-, szulfonsav-, szulfonil-amino-, illetve szulfinil-amino-N-[amino-imino-metil)-fenil-alkil]-aza-heterociklil-amid-származékok és a vegyületeket tartalmazó gyógyászati készítmények | |
HUP9600448A2 (hu) | Naftilvegyületek, e vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra, intermedierjeik és alkalmazásuk | |
HUP0202758A2 (hu) | Izomer kondenzált pirrolokarbazolok és izoindolok és intermedierjeik, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
NO308736B1 (no) | 1,2-difenylpyrrolderivater, farmasøytiske preparater inneholdende disse, og deres anvendelse | |
NO306992B1 (no) | Quinolinderivater, farmasoeytiske preparater inneholdende forbindelsene og anvendelsen av forbindelsene | |
HUP9903527A2 (hu) | Pirazolo-piridin-származékok, alkalmazásuk, ezeket tartalmazó gyógyászati készítmények és eljárás előállításukra | |
NO880964L (no) | Analogifremgangsmaate for fremstilling av anticancer legemiddel. | |
HUP9801766A2 (hu) | 6-Karboxamido-dihidropirán-származékok, eljárás előállításukra és azokat tartalmazó gyógyszerkészítmények | |
NO162235C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinforbindelser. | |
HUP0001858A2 (hu) | Biaromás vegyületek, ezeket tartalmazó gyógyászati és kozmetikai készítmények, valamint e vegyületek alkalmazása | |
KR910004569A (ko) | 고리형 치환체를 갖는 (퀴놀린-2-일-메톡시)페닐아세트산 유도체 | |
HUP9901376A2 (hu) | 1-Metil-karbapenem-származékok, alkalmazásuk, előállításuk, ezeket tartalmazó gyógyszerkészítmények | |
DK183789D0 (da) | 2-alkyl-3-benzoylbenzofuraner og laegemidler indeholdende disse | |
HUP9901212A2 (hu) | N,N-dialkil-N-[2-(3-alkoxi-fenoxi)-etil]-amin-származékok, az ezeket tartalmazó gyógyszerkészítmények és helyi érzéstelenítőkként való alkalmazásuk | |
FR2445330A1 (fr) | Derives du 11-bromo-14,15-dioxo-e-homo-eburnane leur preparation et leur utilisation comme medicament | |
DE69103630D1 (de) | Oxazolederivate, ihre herstellung und diese enthaltende pharmazeutischen zubereitungen. | |
HUP9700810A2 (hu) | Diozmetinsavak és -észterek, és a vegyületeket tartalmazó gyógyszerkészítmények | |
FR2392990A1 (fr) | Medicament a base d'un compose heterocyclique bicyclique condense | |
EP0304271A3 (en) | Omega-arylsulphonamidoalkanoic acids for treatment of thromboxane medited diseases | |
HUP0300265A2 (hu) | Aril- és heteroaril-szulfonátok, eljárás előállításukra és gyógyászati alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények | |
FR2377997A1 (fr) | Aralcoylanilines utilisables comme medicament |